BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11088001)

  • 1. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
    Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
    J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
    Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.
    Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Théveniau M; Nahmias C; Vaysse N; Susini C
    J Biol Chem; 1997 Sep; 272(39):24448-54. PubMed ID: 9305905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
    Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
    Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.
    Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; degli Uberti EC
    Endocrinology; 2005 Jun; 146(6):2692-8. PubMed ID: 15746253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors.
    Alderton F; Humphrey PP; Sellers LA
    Mol Pharmacol; 2001 May; 59(5):1119-28. PubMed ID: 11306695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.
    Florio T; Rim C; Hershberger RE; Loda M; Stork PJ
    Mol Endocrinol; 1994 Oct; 8(10):1289-97. PubMed ID: 7854346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
    Guillemot L; Levy A; Zhao ZJ; Bereziat G; Rothhut B
    J Biol Chem; 2000 Aug; 275(34):26349-58. PubMed ID: 10843991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1.
    Bousquet C; Delesque N; Lopez F; Saint-Laurent N; Estève JP; Bedecs K; Buscail L; Vaysse N; Susini C
    J Biol Chem; 1998 Mar; 273(12):7099-106. PubMed ID: 9507021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.
    Reardon DB; Dent P; Wood SL; Kong T; Sturgill TW
    Mol Endocrinol; 1997 Jul; 11(8):1062-9. PubMed ID: 9212054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
    Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.
    Guillemot L; Levy A; Raymondjean M; Rothhut B
    J Biol Chem; 2001 Oct; 276(42):39394-403. PubMed ID: 11502738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
    Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
    Frearson JA; Alexander DR
    J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent roles of SHP-2 in ERK activation by leptin receptors.
    Bjørbaek C; Buchholz RM; Davis SM; Bates SH; Pierroz DD; Gu H; Neel BG; Myers MG; Flier JS
    J Biol Chem; 2001 Feb; 276(7):4747-55. PubMed ID: 11085989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.